We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Microcapsule Traps and Kills Harmful Bacteria

By LabMedica International staff writers
Posted on 11 Dec 2008
American researchers are reporting the development of microscopic particles that act as chemical traps for bacteria. More...
The traps attract and kill up to 95% of nearby bacteria, including microbes responsible for troublesome hospital-based infections. The scientists described their discovery as micro-sized "roach motels” for harmful bacteria.

In the study, Dr. David G. Whitten, from the University of New Mexico (Albuquerque, USA), and Dr. Kirk S. Schanze, from the chemistry department of the University of Florida (Gainesville, USA), working together with a team of faculty and graduate student collaborators, pointed out that bacterial contamination of medical devices causes up to 1.4 million deaths per year. Moreover, bacteria are becoming more resistant to conventional methods of disinfection. Scientists also are increasingly concerned about the possibility of intentional release of harmful bacteria by terrorists. As a result, researchers are attempting to develop new and improved methods of disinfection.

The New Mexico and Florida teams of researchers study involved the development of light-activated, hollow microcapsules composed of an organic conducting polymer. The antibacterial microcapsules can attract, capture, and destroy bacteria. In controlled laboratory tests, the researchers exposed the capsules to either Pseudomonas aeruginosa, one of the deadliest and most common hospital-based pathogens, or Cobetia marina, a type of bacterium that soils the hulls of ships and other marine equipment. After one hour of light exposure, the light-activated capsules killed more than 95% of the exposed bacteria, the researchers reported. The microcapsules can be applied to a variety of surfaces, including medical equipment, they added.

The scientists' study was published online, ahead of print, on November 24, 2008, in the first issue of a new journal, Applied Materials & Interfaces.

Related Links:
University of New Mexico



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Electrolyte Analyzer
BKE-B
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.